SUMMARY Ten infants under the age of 1 year each of whom gave a history of recurrent wheezing attacks were studied with a total body plethysmograph. All the infants were free of wheeze when studied and were sedated with chloral hydrate. All 10 showed a significant deterioration in lung function when given nebulised water for two minutes with an increase in airways resistance and a decrease in specific conductance at one and five minutes after nebulisation compared with baseline readings. Measurements returned to baseline values within 15 minutes. When the same amount of nebulised water was given 20 minutes after nebulised salbutamol, however, there was no significant deterioration in lung function at one and five minutes after administration of nebulised water.
SUMMARY Ten infants under the age of 1 year each of whom gave a history of recurrent wheezing attacks were studied with a total body plethysmograph. All the infants were free of wheeze when studied and were sedated with chloral hydrate. All 10 showed a significant deterioration in lung function when given nebulised water for two minutes with an increase in airways resistance and a decrease in specific conductance at one and five minutes after nebulisation compared with baseline readings. Measurements returned to baseline values within 15 minutes. When the same amount of nebulised water was given 20 minutes after nebulised salbutamol, however, there was no significant deterioration in lung function at one and five minutes after administration of nebulised water. We conclude that the airways were protected against the bronchoconstricting effect of nebulised water by the 12 adrenoreceptor stimulant salbutamol.
Many doctors believe that (32 adrenoreceptor stimulants have little or no effect on the airways of infants under the age of 1 year. These children do, however, have (2 adrenoreceptors' and smooth muscle2 in their airways and theoretically should respond to (32 adrenergic stimulants. Nebulised water has a bronchoconstricting effect on asthmatic children and adults,37 and we have found that it also causes bronchoconstriction in wheezy infants (unpublished data).
The present study was designed to find out if nebulised salbutamol protects the airways of wheezy infants. Nebulised water was used as a bronchoconstricting challenge.
Patients and methods
Patients studied were under 1 year old and attending this hospital for routine assessment. All had had more than two wheezy episodes in the preceding months. Table 1 shows their age, sex, and history of bronchiolitis. At the time of the study all were clinically well and at least four months had elapsed since their bronchiolitic illnesses. Each study was done in the outpatient clinic, all patients were awake, and allowed home within three hours of arrival.
The infants were sedated with chloral hydrate (120 mg/kg), and thoracic gas volume and airways resistance were measured with total body plethysmography.i" The total body plethysmograph had a capacity of 260 litres, and a servo controlled heating system maintained the face mask, shutter system, and rebreathing bag at 36°C. Thoracic gas volume was measured at the end of inspiration, and the tidal volume was subtracted before calculation. The children were nursed supine and firm latex masks applied to their faces. The dead space of each mask was 88 ml. There was a bias flow of air at 5 1/minute to the face mask. Signals were relayed to the axis of a cathode ray oscilloscope, all readings were made by the same observer, given salbutamol (0.5 ml salbutamol respirator solution in 1-5 ml normal saline) through a Cirrhus nebuliser chamber at a flow rate of 6 1/minute for five minutes. Thoracic gas volume and airways resistance were measured at regular intervals until they had returned to baseline measurements. Nebulised water was then given through the ultrasonic 31-5 (12) 20(4 (2) (3) (4) (5) (118 ((1-1)5) 19-( (3-4) 0(2 (() (1)5) 192 (119 (0.04) (fig 1) . There were also significant decreases in specific conductance one minute after the water had been given (p<0.01); and five minutes after it had been given (p<O.0Ol); these had returned to baseline values after 10 minutes (fig 2) . nebulised water 20 minutes after nebulised salbutamol had been given however, there were no significant changes in airways resistance (p>0.5) or specific conductance (p>05) (fig 1) . There were no significant changes in thoracic gas volume after any of the challenges. There were no abnormalities in the electrocardiographic traces, and oxygen saturation did not fall below 84% in any of the patients during the study.
Discussion
Subjective clinical observations have suggested that nebulised bronchodilators are helpful in treating some wheezy infants. There is little evidence from clinical trials, however, to recommend treatment of such infants with bronchodilators. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Nebulised water produces bronchoconstriction in asthmatic subjects.7 In the 10 infants we studied all of whom had history of wheezing, we confirmed that nebulised water in the regimen we gave caused bronchoconstriction. The measurements showing deterioration in lung function correlated well with the patients' clinical signs during the study. When rechallenged with the same amount of nebulised water 20 minutes after receiving nebulised salbutamol, however, there was no evidence of bronchoconstriction; the salbutamol had protected the airways.
Prendiville et al studied five infants and found that salbutamol had a similar protective effect when histamine was used as the challenge.' The results of this and the present study show that P2 adrenoreceptors do exist in infants.
The amount of nebulised water given is derived from the results of 20 studies we performed before this trial (unpublished data). We found that repeated stimuli with nebulised water also produced bronchoconstriction. This suggested that the lack of response to the administration of nebulised water after being given salbutamol was not because there was a refractory period after the original bronchoconstricting challenge.
Hypo-osmolar solutions cause the release of histamine from mast cells24 and we presume that this may be the cause of the bronchoconstriction seen in our infants, the histamine acting either directly on the smooth muscle or by reflex action on the vagus nerve.
During the studies some of the infants seemed clinically worse immediately after the administration of salbutamol. After completing the study we looked at a further 17 infants all of whom gave a history of wheezing.25 In 13 of the 17 infants there was a rise in airways resistance and a fall in specific conductance when they were challenged with nebulised water. They also showed significant increases in airways resistance and decreases in specific conductance after nebulised salbutamol had been given. We feel this may have been partly caused by the acid and preservatives in the solution. Until we have found out the specific cause of the paradoxical deterioration and how to eliminate it we cannot recommend the use of nebulised salbutamol at home for infants under 1 year old.
The validity of thoracic gas volume measurements in wheezy infants has recently been questioned by Godfrey et al.26 They found low thoracic gas volume measurements in wheezy infants who had had bronchiolitis that were difficult to explain. In some of our patients the measurements were surprisingly low, and they changed remarkably little during the challenge procedures.
We used the plethysmograph to look for changes in the airway function of our infants and we feel that this is a valid use of it.
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